GENERAL ORTHOPAEDICS
Kashin-Beck disease: Chondroitin sulfate plus Glucosamine reduces pain and stiffness
This report has been verified
by one or more authors of the
original publication.
Osteoarthritis Cartilage. 2012 Jul;20(7):622-9. Epub 2012 Mar 30.
251 patients with Kashin-Beck disease (KBD) were randomized to receive oral administration of either chondroitin sulfate, glucosamine hydrochloride, a combination of chondroitin sulfate and glucosamine hydrochloride, or a placebo. The results following 6 months of treatment indicate that the combined treatment of chondroitin sulfate and glucosamine hydrochlroide is more effective in providing KBD patients with reduced pain and stiffness, compared to placebo treatment.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
